Po-Ming Chen
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Breast Cancer Treatment Studies
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- Oncology top 10%
- Cancer Cells and Metastasis
Papers in
-
- MicroRNA in disease regulation 7
- Breast Cancer Treatment Studies 5
- NF-κB Signaling Pathways 3
-
- Hepatocellular Carcinoma Treatment and Prognosis 8
- Co-authors
- Pei‐Yi Chu (16 shared papers)Ya‐Wen Cheng (7 shared papers)Huei Lee (9 shared papers)Chih‐Yi Chen (7 shared papers)Wei-Chieh Huang (7 shared papers)Shiao-Lin Tung (6 shared papers)Tzu‐Chin Wu (5 shared papers)Yao‐Li Chen (5 shared papers)
- Journals
- International Journal of Molecular Sciences (6 papers)BMC Cancer (3 papers)Oncotarget (3 papers)Journal of Biomedical Science (2 papers)Cells (2 papers)
- Partner nations
- TaiwanChinaUnited States
In The Last Decade
Po-Ming Chen
53 papers receiving 1k citations
Peers
Comparison fields: 5 of 79
- Cancer Research 275
- Oncology 229
- Otorhinolaryngology 36
- Hepatology 41
- Molecular Biology 269
Countries citing papers authored by Po-Ming Chen
This map shows the geographic impact of Po-Ming Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Po-Ming Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Po-Ming Chen more than expected).
Fields of papers citing papers by Po-Ming Chen
This network shows the impact of papers produced by Po-Ming Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Po-Ming Chen. The network helps show where Po-Ming Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Po-Ming Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 103 | |
| 2 | 2022 | 82 | |
| 3 | 2015 | 51 | |
| 4 | 2016 | 48 | |
| 5 | 2014 | 47 | |
| 6 | 2018 | 47 | |
| 7 | 2012 | 46 | |
| 8 | 2017 | 44 | |
| 9 | 2018 | 42 | |
| 10 | 2012 | 41 | |
| 11 | 2013 | 41 | |
| 12 | Ultrasonography and clinical outcome comparison of extracorporeal shock wave therapy and corticosteroid injections for chronic plantar fasciitis: A randomized controlled trial. | 2018 | 36 |
| 13 | 2018 | 36 | |
| 14 | 2014 | 34 | |
| 15 | 2020 | 30 | |
| 16 | ABCG2 Overexpression Confers Poor Outcomes in Hepatocellular Carcinoma of Elderly Patients. | 2016 | 29 |
| 17 | 2017 | 25 | |
| 18 | 2021 | 22 | |
| 19 | 2021 | 21 | |
| 20 | 2015 | 17 |
About Po-Ming Chen
Po-Ming Chen is a scholar working on Cancer Research, Hepatology, Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 54 papers that have together received 1k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (8 papers), MicroRNA in disease regulation (7 papers), Breast Cancer Treatment Studies (5 papers), Lung Cancer Treatments and Mutations (4 papers), Cancer Cells and Metastasis (4 papers), Lung Cancer Research Studies (4 papers), Cancer-related Molecular Pathways (3 papers) and NF-κB Signaling Pathways (3 papers). The work is most often cited by research in Cancer Research (275 citations), Oncology (229 citations), Otorhinolaryngology (36 citations), Hepatology (41 citations) and Molecular Biology (269 citations). Po-Ming Chen has collaborated with scholars based in Taiwan, China and United States. Frequent co-authors include Pei‐Yi Chu, Ya‐Wen Cheng, Huei Lee, Chih‐Yi Chen, Wei-Chieh Huang, Shiao-Lin Tung, Tzu‐Chin Wu, Yao‐Li Chen, Lu‐Hai Wang and Yayu Yang. Their work appears in journals such as International Journal of Molecular Sciences, BMC Cancer, Oncotarget, Journal of Biomedical Science and Cells.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.